ArticleFrontiers in oncology2025

Durable response to Olaparib in EGFR and somatic BRCA2-mutated lung adenocarcinoma with leptomeningeal metastases: a case report.

Fang-Fang Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.